Ignite Creation Date:
2024-05-06 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05697874
Status:
RECRUITING
Last Update Posted:
2024-02-13
First Post:
2023-01-23
Brief Title:
International Rare Brain Tumor Registry
Sponsor:
Childrens National Research Institute
Organization:
Childrens National Research Institute
Study Overview
Official Title:
International Rare Brain Tumor Registry
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IRBTR
Brief Summary:
The objective of the International Rare Brain Tumor Registry IRBTR is to better understand rare brain tumors through the collection of biospecimens and matched clinical data of children adolescents and young adult patients diagnosed with rare brain tumors
Detailed Description:
The International Rare Brain Tumor Registry IRBTR is a prospective observational study that will collect tumor samples and matched clinical and radiological data to better understand the outcomes of patients with rare brain tumors in particular CNS sarcoma BCOR MN-1 altered tumors and other unclassified rare brain tumors
Data collected include demographics disease characteristics treatment information radiological imaging and biospecimen collection if available tumor tissues Patients will be followed longitudinally to obtain outcome data Data collection will continue for approximately 10 years
Data collected include demographics disease characteristics treatment information radiological imaging and biospecimen collection if available tumor tissues Patients will be followed longitudinally to obtain outcome data Data collection will continue for approximately 10 years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None